Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | TPB | Common Stock | 139K | Feb 3, 2022 | Direct | F11 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TPB | Dividend Equivalent Right | Award | $0 | +213 | $0.00 | 213 | Feb 3, 2022 | Common Stock | 213 | Direct | F12, F13 | ||
transaction | TPB | Dividend Equivalent Right | Disposed to Issuer | -213 | -100% | 0 | Apr 29, 2022 | Common Stock | 213 | Direct | F12, F14 | |||
holding | TPB | Options (2022) | 12K | Feb 3, 2022 | Common Stock | 12K | $30.46 | Direct | F2, F10 | |||||
holding | TPB | Options (2021) | 9K | Feb 3, 2022 | Common Stock | 9K | $51.75 | Direct | F4, F9 | |||||
holding | TPB | Options (2020) | 11K | Feb 3, 2022 | Common Stock | 11K | $14.85 | Direct | F4, F8 | |||||
holding | TPB | Options (2019) | 5.5K | Feb 3, 2022 | Common Stock | 5.5K | $47.58 | Direct | F4, F7 | |||||
holding | TPB | Options (2018) | 8.9K | Feb 3, 2022 | Common Stock | 8.9K | $21.21 | Direct | F4, F6 | |||||
holding | TPB | Options (2017) | 5K | Feb 3, 2022 | Common Stock | 5K | $15.41 | Direct | F4, F5 | |||||
holding | TPB | Options (2014) | 5.22K | Feb 3, 2022 | Common Stock | 5.22K | $3.83 | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Granted pursuant to the issuer's 2006 Equity Plan |
F2 | Granted pursuant to the issuer's 2021 Equity Incentive Plan. |
F3 | The options vested and became exercisable as to 50% of the underlying shares on August 8, 2014, 25% of the underlying shares on August 8, 2015 and 25% of the underlying shares on August 8, 2016. |
F4 | Granted pursuant to the issuer's 2015 Equity Incentive Plan. |
F5 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020. |
F6 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021. |
F7 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022. |
F8 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022, and 33% of the underlying shares on January 1, 2023. |
F9 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023, and 33% of the underlying shares on January 1, 2024. |
F10 | The options vest and become exercisable as to 34% of the underlying shares on January 1, 2023, 33% of the underlying shares on January 1, 2024, and 33% of the underlying shares on January 1, 2025. |
F11 | The total reported in Column 5 includes 2,500 awarded restricted stock units and 136,484 shares of common stock. |
F12 | Each dividend equivalent right was the economic equivalent of one share of the Company's common stock. |
F13 | In connection with the vesting and settlement of previously-granted performance-based restricted stock units, which settled in shares of the Company's common stock on February 3, 2022, the reporting person acquired 213 fully-vested dividend equivalent rights pursuant to the terms of the applicable award agreement. |
F14 | On April 29, 2022, the dividend equivalent rights were disposed of and cancelled in exchange for a cash payment equal to $7,220.85. |